Cannabinoid Ratio
Category: Medical · Level: Intermediate
Cannabinoid ratio refers to the proportion of different cannabinoids (particularly THC to CBD) in a cannabis product, used to characterize its effect profile and therapeutic potential.
Cannabinoid ratio describes the relative proportions of cannabinoids in a cannabis product, most commonly expressed as a THC:CBD ratio. Common ratio categories include high THC:low CBD (e.g., 20:1), balanced THC:CBD (1:1), and high CBD:low THC (e.g., 1:20). Ratios have clinical significance: high-CBD products are often preferred by patients seeking therapeutic benefits without significant psychoactivity; balanced ratios are used in products like Sativex for specific indications; high-THC products are standard in adult-use markets. Understanding cannabinoid ratios is essential for medical cannabis dosing and for evaluating the suitability of products for specific therapeutic applications.
Also known as
THC:CBD ratio, Cannabinoid profile ratio
Usage
- Medical
Related terms
- THC — Tetrahydrocannabinol (THC) is the primary psychoactive cannabinoid in cannabis, responsible for the 'high' associated with its use.
- Bioavailability — Bioavailability is the proportion of a consumed dose of a cannabinoid that reaches systemic circulation and is available to exert its effects.
- CBD — Cannabidiol (CBD) is a non-psychoactive cannabinoid found in cannabis and hemp, widely used in medical research and consumer wellness products.
- Medical Cannabis — Medical cannabis refers to cannabis or cannabis-derived products prescribed or recommended by a licensed healthcare professional for therapeutic purposes.